Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,013 | 101,076 | 45,791 | 40,046 | 30,017 |
| Marketable Securities | 183,295 | 131,511 | 94,407 | 46,976 | 77,027 |
| Receivables | 28,770 | 8,047 | 391 | 220 | 207 |
| TOTAL | $302,372 | $254,855 | $145,453 | $90,840 | $113,173 |
| Non-Current Assets | |||||
| PPE Net | 5,008 | 4,479 | 4,532 | 4,488 | 3,962 |
| Investments And Advances | 32,476 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 935 | 1,122 | 1,063 | 1,184 | 1,233 |
| TOTAL | $38,419 | $5,601 | $5,595 | $5,672 | $5,195 |
| Total Assets | $340,791 | $260,456 | $151,048 | $96,512 | $118,368 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,938 | 11,824 | 9,247 | 8,797 | 10,968 |
| Accrued Expenses | 10,277 | 36,812 | 10,121 | 9,111 | 7,705 |
| Other current liabilities | 1,249 | N/A | N/A | N/A | N/A |
| TOTAL | $33,001 | $57,984 | $42,093 | $33,515 | $33,936 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,815 | 19,971 | 17,636 | 19,742 | 21,749 |
| Deferred Revenues | 2,498 | 5,654 | 16,959 | 12,209 | 14,134 |
| Other Non-Current Liabilities | 1,238 | 2,487 | 2,487 | 2,487 | 2,487 |
| TOTAL | $39,830 | $43,636 | $37,185 | $39,586 | $43,618 |
| Total Liabilities | $72,831 | $101,620 | $79,278 | $73,101 | $77,554 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,310 | 3,593 | 3,579 | 3,551 | 3,088 |
| Common Shares | 43 | 36 | 36 | 31 | 31 |
| Retained earnings | -156,879 | -151,148 | -236,514 | -226,200 | -207,592 |
| Other shareholders' equity | 64 | 20 | -20 | 0 | 16 |
| TOTAL | $267,960 | $158,836 | $71,770 | $23,411 | $40,814 |
| Total Liabilities And Equity | $340,791 | $260,456 | $151,048 | $96,512 | $118,368 |